Cargando…

Assessment of the tumor immune-environment in patients with head and neck cancer

Detalles Bibliográficos
Autores principales:	Feng, Zipei, Bethmann, Daniel, Kappler, Matthias, Ballesteros-Merino, Carmen, Eckert, Alexander, Bell, R Bryan, Cheng, Allen, Bui, Tuan, Leidner, Rom, Bifulco, Carlo, Wickenhauser, Claudia, Fox, Bernard A, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646048/ http://dx.doi.org/10.1186/2051-1426-3-S2-P86

Ejemplares similares

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
por: Seliger, Barbara, et al.
Publicado: (2020)

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer
por: Montler, Ryan, et al.
Publicado: (2016)

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma
por: Wickenhauser, Claudia, et al.
Publicado: (2021)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
por: Duhen, Rebekka, et al.
Publicado: (2021)

Explant Modeling of the Immune Environment of Head and Neck Cancer
por: Sharon, Shay, et al.
Publicado: (2021)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes
por: Duhen, Thomas, et al.
Publicado: (2022)

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies
por: Knorr, David, et al.
Publicado: (2023)

Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2020)

Adoptive TIL in HPV-negative oral scca
por: Leidner, Rom, et al.
Publicado: (2015)

In vitro models as tools for screening treatment options of head and neck cancer
por: Seliger, Barbara, et al.
Publicado: (2022)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
por: Leidner, Rom, et al.
Publicado: (2021)

Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2016)

Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2018)

Prognostic impact of cytoplasmatic EGFR upregulation in patients with oral squamous cell carcinoma: A pilot study
por: Kappler, Matthias, et al.
Publicado: (2020)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
por: Falchook, Gerald S., et al.
Publicado: (2016)

Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2019)

Multispectral imaging and objective assessment of immune-tumor interactions in non-small cell lung cancer
por: Ballesteros-Merino, Carmen, et al.
Publicado: (2015)

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
por: Andtbacka, Robert HI, et al.
Publicado: (2015)

An image analysis algorithm based on the hue saturation density transformation, an important tool for melanoma immunotherapy research
por: Dzubay, Jeffrey A, et al.
Publicado: (2014)

Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
por: Rot, Swetlana, et al.
Publicado: (2019)

Immunotherapy in head and neck squamous cell carcinoma: a narrative review
por: Sharon, Shay, et al.
Publicado: (2022)

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
por: Feng, Zipei, et al.
Publicado: (2015)

Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2021)

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer
por: van de Ven, Rieneke, et al.
Publicado: (2013)

STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2017)

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer
por: Leidner, Rom S., et al.
Publicado: (2013)

Multispectral imaging of T and B cells in murine tissue
por: Feng, Zipei, et al.
Publicado: (2015)

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies
por: Fox, Bernard A., et al.
Publicado: (2023)

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
por: Kallinteris, Nikoletta L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oa18a0378hnhtsav27osscim83